Assessment of endothelial dysfunction in idiopathic pulmonary fibrosis

[1]  B. Nordestgaard,et al.  Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study. , 2010, American journal of respiratory and critical care medicine.

[2]  R. Hubbard,et al.  The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. , 2008, American journal of respiratory and critical care medicine.

[3]  M. Kramer,et al.  Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension. , 2008, Respiratory medicine.

[4]  A. Borczuk,et al.  Pulmonary hypertension in idiopathic pulmonary fibrosis. , 2007, Chest.

[5]  Y. Castier,et al.  Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics. , 2007, Human pathology.

[6]  T. Ece,et al.  Endothelial Function in Patients with Obstructive Sleep Apnea Syndrome but without Hypertension , 2006, Respiration.

[7]  M. Frid,et al.  Hypoxia-induced Pulmonary Vascular Remodeling Cellular and Molecular Mechanisms Reviews , 2022 .

[8]  J. Lordan,et al.  Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary arterial hypertension. , 2005, Chest.

[9]  E. Bossone,et al.  Pulmonary arterial hypertension: the key role of echocardiography. , 2005, Chest.

[10]  C. Stefanadis,et al.  Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques , 2005, Heart.

[11]  S. Hazen,et al.  Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  R. Naeije,et al.  Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension , 2004, Circulation.

[13]  D. Mccrory,et al.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[14]  A. Torbicki,et al.  Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[15]  S. Kimmel,et al.  Association between pulmonary fibrosis and coronary artery disease. , 2004, Archives of internal medicine.

[16]  J. Keaney,et al.  The clinical implications of endothelial dysfunction. , 2003, Journal of the American College of Cardiology.

[17]  M. Humbert,et al.  Inflammation in pulmonary arterial hypertension , 2003, European Respiratory Journal.

[18]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[19]  M. Humbert,et al.  Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. , 2001, The Journal of clinical investigation.

[20]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[21]  R. Barst,et al.  Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. , 1997, Circulation.

[22]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.